Paper published (16 Feb 2022) by Dept. of Health #Australia about utilisation of antimicrobials used to treat bacterial pneumonia in principal referral hospitals during the COVID-19 pandemic in 2020 beg some serious question.
The paper mentions:-
"Overall usage (in 2020) of doxycycline, azithromycin, amoxicillin and cefuroxime decreased in principal referral hospitals compared to 2019." in #Australia
Please note, to treat bacterial pneumonia, you need doxycycline or azithromycin.
Antibacterials usage to treat community-acquired pneumonia in 2020 was not same as 2019
"In the non-critical-care setting, usage of oral amoxicillin and of oral azithromycin for the July to December period fell, on average, by 21.1% and 23.7% respectively between 2019 and 2020."
The paper mentions that data submitted to National Antimicrobial Utilisation Surveillance Program (NAUSP) in #Australia reflects dispensing and/or distribution, not actual consumption.
Hospitals were perhaps stocking up (Mar/April 2020) anticipating demand.
Paper also mentions that pandemic related interventions may have unintended benefits on non SARS-CoV-2 infections rates such as community-acquired pneumonia (CAP) - Can this be true?
Lab confirmed influenza was 8 times lower that the five-year avg.
A different report published by Dept. of Health #Australia about Antimicrobial use in Australian Hospitals during 2020 compared to 2019 which mentions that the total annual use of the macrolides (including azithromycin) fell across Australia (15.5% decline).
A very interesting entry in the report:-
"The reduction in hospital usage of antibacterials commonly used to treat community-acquired pneumonia, such as doxycycline and azithromycin, may be due to a reduction in the number of pneumonia cases in 2020."
So, if Lab confirmed influenza was all time low AND there was reduction in community-acquired pneumonia (CAP) then what happened in 2020 in #Australia ? What caused so many deaths?
On 17 Oct 2024, Doherty Institute (Melbourne, Australia) published a study in American Chemical Society Nano that provided the first detailed analysis of how mRNA vaccines (COVID-19) circulate and break down in the human bloodstream.
Below are few excerpts from the study/paper:
- These vaccines (COVID-19 mRNA vaccines) are designed to stay in the lymph nodes, but the researchers say a tiny amount of the vaccine also found its way into the bloodstream.
- Extent to which vaccines enters the bloodstream varies between individuals and may explain the side effects after vaccination.
- Understanding the causal relationship between the amount of vaccine circulating in the blood and these reported side effects will be an important area for future research.
"Despite the above, researchers assure that the mRNA vaccines are safe and effective."
Study revealed how mRNA and its fatty nanoparticle shell peaked in the bloodstream within two days after vaccination. In some cases, the mRNA remains detectable for up to a month.
Researchers initially predicted it was the antibodies formed in response to a commonly used vaccine compound, known as polyethylene glycol (PEG), that dictated how long a vaccine stayed in the bloodstream. However, the research team found anti-PEG antibodies were not the only factor impacting this process.
Dr Ju said the breakdown of mRNA in the body was likely also influenced by a complex mix of individual factors.
“The mRNA vaccine in the bloodstream is like a message in a bottle. It’s protected by its shell – the fatty nanoparticles – as it travels, but its fate depends on how the body responds to the bottle, not just the message inside,” Dr Ju said.
“However, we still found that higher levels of mRNA and fatty nanoparticles in the blood were linked to a bigger increase in anti-PEG antibodies, suggesting that some individuals may develop more antibodies to PEG.”
- By understanding the biodistribution of these components we can better inform future vaccine designs to minimise risks.
- Further research could also help to find a way to prevent vaccines (mRNA) entering the bloodstream.
Questions: 1. How does mRNA and fatty nanoparticles being present in the blood impact the health long term?
2. What does "Tiny amount of Vaccine" mean? Is it quantifiable?
3. We were told (2021) that the vaccine remains at the injection site (deltoid) and drains through the lymphatic system. If it is finding its way into the bloodstream, that means it is getting to all the organs?
There were and still are (even after 4 years) so many unknow and this useless dangerous product was and is still mandated in some workplaces in Australia to keep their livelihood.
- The regulatory bodies are captured.
- The Health system is run by clowns.
- The entire diseased corrupt system must be brought down on their heads by exposing their lies and rebuilt from the ground up.
"This is consistent with PEG being expressed on the surface of the lipid nanoparticle, whereas the spike protein, the target of neutralization and spike binding IgG, is only expressed following the mRNA transfection of cells."
Dept. of Health Australia has introduced a new permanent MBS item code (63390) from 1 Jan 2025 to diagnose myocarditis in acute onset heart failure or unexplained arrhythmia, or in suspected drug induced myocarditis.
What is going on ??!! 👀
@Jikkyleaks
#Australia
Please note, for the new item code 63390, the term ‘drug’ includes pharmaceutical preparations such as mRNA vaccinations.
@Jikkyleaks @razorback11111 @SenatorRennick
#Australia
#mRNA
63390 item (new) replaces temporary cardiac MRI item 63399 (old), which was first introduced in January 2022 to assist in diagnosing myocarditis that may occur after vaccination with the mRNA COVID-19 vaccines.
A FOI (OGTR 051) was submitted to the Office of Gene Technology Regulator (OGTR) requesting information about how OGTR determine self-amplifying mRNA (sa-mRNA) as a GMO.
A 🧵
#Australia
#mRNA
OGTR responds to a query that about mRNA vaccines.
- mRNA COVID-19 vaccines are excluded from regulation.
- saRNA vaccines are considered GMOs on the basis that the nucleic acid is capable of reproduction.
NINE MONTHS have passed since .@SenatorRennick and .@Jikkyleaks called out the Office of Gene Technology Regulator (OGTR), which is part of Dept. of health Australia on their position of why COVID-19 mRNA vaccines are not Gene Therapy and the regulators convoluted response implying it is - they are still crying 'misinformation'.
Here is there latest (26 June 2024) statement on mRNA COVID-19 vaccines are not gene therapies.
The Office of Gene Technology Regulator (OGTR) issued a similar statement on 6 December 2023, after the exchange (next tweet) between .@SenatorRennick and Raj Bhula (current OGTR regulator) from Senate Estimates hearing blew up in social media.
Those who are not aware, this stems from the iconic thread shared by .@Jikkyleaks where .@SenatorRennick called out Dr. Raj Bhula who is the current regulator (OGTR).
Australian Centre for Disease Control has recently published their analysis of adverse event following COVID-19 vaccination in Australia for 2021.
I am sharing few excerpts from the article in this 🧵
#Australia
#mRNA
#COVIDVACCINE
The COVID-19 AEFI reporting rate was 507.8
per 100,000 population, in people aged ≥ 12 years,
reflecting that many people received more than one
dose of vaccine. These reporting rates were markedly greater (38-fold) than the annual AEFI reporting rate for non-COVID-19 vaccines.
“The annual dose-based AEFI reporting rate was still greater than the annual AEFI reporting rate for non-COVID-19 vaccines of 30.6 per 100,000 doses (all ages) for the same year.”
Dept. of Health Australia has updated their Guidance on Myocarditis and Pericarditis after COVID-19 vaccines on 12 January 2024.
Here are some interesting points 👇🏽
#Australia
#CovidVaccines
In the guidance published on 9 Nov 2022, they said that a small number of cases of have been reported in the clinical trial and in Australia. Now, they are saying that Myocarditis and/or pericarditis can occur after Novavax at a similar rate to the mRNA vaccine.
Myocarditis - 4 in every 100K doses.
Pericarditis - 13 in every 100K doses.